Compounds > geranylgeraniol
Page last updated: 2024-08-24

geranylgeraniol and Ovarian Neoplasms

geranylgeraniol has been researched along with Ovarian Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdullah, MI; de Wolf, E; Drijfhout, FP; Hart, SR; Hoskins, C; Jones, SM; Menezes, K; Moss, DM; Richardson, A; Stronach, EA1
Abdullah, MI; Abed, MN; Richardson, A1
Ikebuchi, Y; Kawagishi, R; Morishige, K; Murata, Y; Sawada, K; Tahara, M; Tasaka, K1
Aiuchi, T; Nakajo, S; Nakaya, K; Sakairi, S; Shibayama-Imazu, T; Watanabe, A1
Aiuchi, T; Ann, WW; Itabe, H; Nakajo, S; Nakaya, K; Sakairi, S; Shibayama-Imazu, T; Sonoda, I1

Other Studies

5 other study(ies) available for geranylgeraniol and Ovarian Neoplasms

ArticleYear
Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.
    Scientific reports, 2017, 07-14, Volume: 7, Issue:1

    Topics: Animals; Cell Line; Cell Line, Tumor; Cells, Cultured; Diet; Diterpenes; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice, Nude; Mice, SCID; Ovarian Neoplasms; Quinolines; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2017
Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells.
    Scientific reports, 2017, 08-14, Volume: 7, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Diterpenes; Female; Geranyltranstransferase; GTP Phosphohydrolases; Humans; Imidazoles; Leucine; Mevalonic Acid; Naphthalenes; Ovarian Neoplasms; Quinolines; Zoledronic Acid

2017
Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.
    Cancer research, 2002, Nov-01, Volume: 62, Issue:21

    Topics: Alendronate; Cell Movement; Cell Survival; Cytoskeletal Proteins; Diterpenes; Drug Interactions; Enzyme Activation; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Myosin Light Chains; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; rho GTP-Binding Proteins; Tumor Cells, Cultured; Tyrosine

2002
Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol.
    Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:1

    Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Division; Cell Separation; Cytochrome c Group; Diterpenes; DNA Fragmentation; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Male; Mitochondria; Ovarian Neoplasms; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vitamin K

2003
Production of superoxide and dissipation of mitochondrial transmembrane potential by vitamin K2 trigger apoptosis in human ovarian cancer TYK-nu cells.
    Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:9

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; alpha-Tocopherol; Apoptosis; Cycloheximide; Diterpenes; Female; Humans; Membrane Potentials; Mitochondria; Ovarian Neoplasms; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured; Vitamin K 2

2006